Noa Sher
CSO at Minovia Therapeutics
Living in Haifa, Israel
Dr Sher is a highly experienced research leader in the cell therapy, and passionate about doing great science to serve rare or neglected disease communities. She currently serves as the Chief Scientific Officer at Minovia Therapeutics, a clinical stage company developing a mitochondrial cell therapy approach to treat mitochondrial and hematopoietic diseases.
In previous roles, Noa headed a research team responsible for preclinical development of several clinical stage allogeneic cell therapy products, and founded and headed a bioinformatics and sequencing service unit at the University of Haifa. Noa is a molecular and cellular biologist by training who performed her postdoctoral studies at the Whitehead Institute, MIT, Cambridge, MA and at the Technion Institute of Technology in Israel and earned her PhD in Biochemistry at the Hebrew University. She is passionate about harnessing her industrial experience and her ability to rapidly learn new fields to enable disruptive technologies to improve health, inform decision making, and better wellbeing globally.
In her free time, Noa loves hiking, diving, yoga, pottery, and spending quality time with her husband and three children, preferably on the beach.
